Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Bernard Rudensky
Rofecoxib, a COX-2 Inhibitor, Lowers C-Reactive Protein and Interleukin-6 Levels in Patients With Acute Coronary Syndromes
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
Related publications
C Reactive Protein for Risk Stratification in Acute Coronary Syndromes? Verdict: Unproven
Heart
Gastrointestinal Tolerability of the Selective Cyclooxygenase-2 (COX-2) Inhibitor Rofecoxib Compared With Nonselective COX-1 and COX-2 Inhibitors in Osteoarthritis
Archives of Internal Medicine
Association Between Serum Levels of High Sensitivity C-Reactive Protein, Interleukin-1 and Interleukin-6 With Pain Intensity in Patients With Low Back Pain Without Sciatica
Open Access Macedonian Journal of Medical Sciences
Medicine
Serum Level of Interleukin-33, C-Reactive Protein, and Troponin in Iraqi Coronary Artery Disease Patients
Iraqi Journal of Science
Genetics
Molecular Biology
Geology
Biochemistry
Computer Science
Biotechnology
Chemistry
Prognostic Role of C-Reactive Protein and Interleukin-6 in Dialysis Patients: A Systematic Review and Meta-Analysis
Journal of Nephrology
Nephrology
Interleukin-6 and C-Reactive Protein as Early Markers of Sepsis in Patients With Diabetic Ketoacidosis or Hyperosmosis
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Mechanisms of C-Reactive Protein, Interleukin-6 and Soluble CD40L Blood Concentration Changes After Coronary Stent Implantation
World Journal of Cardiovascular Diseases
Relationship Between C-Reactive Protein to Albumin Ratio and Thrombus Burden in Patients With Acute Coronary Syndrome
Clinical and Applied Thrombosis/Hemostasis
Medicine
Hematology
Prognostic Significance of Angiogenic Growth Factor Serum Levels in Patients With Acute Coronary Syndromes
Circulation
Cardiovascular Medicine
Physiology
Cardiology
